Mesenchymal stem cells in regenerative rehabilitation

Journal of Physical Therapy Science

Volumn 28, Issue 6, 2016, Pages 1943-1948

  Nurkovic, Jasmin ^a,b,c   Dolicanin, Zana ^a,d   Mustafic, Fahrudin ^e   Mujanovic, Rifat ^a   Memic, Mensur ^a   Grbovic, Vesna ^b,c   Skevin, Aleksandra Jurisic ^b,c   Nurkovic, Selmina ^c,d  

^a State University of Novi Pazar   (Serbia)

^b CLINICAL CENTER KRAGUJEVAC   (Serbia)

^c University of Kragujevac Medical Faculty   (Serbia)

^d Department of Hemodialysis   (Serbia)

^e Dental Center Jezero   (Serbia)

Author keywords

Mesenchymal stem cells; Regenerative rehabilitation

Indexed keywords

EID: 84975463120     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.28.1943     Document Type: Review

References (73)

1. Volarevic V, Nurkovic J, Arsenijevic N, et al.: Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells, 2014, 32: 2818-2823. [Medline] [CrossRef]
2. Syková E, Homola A, Mazanec R, et al.: Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant, 2006, 15: 675-687. [Medline] [CrossRef]
3. Geffner LF, Santacruz P, Izurieta M, et al.: Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant, 2008, 17: 1277-1293. [Medline] [CrossRef]
4. Horwitz EM, Gordon PL, Koo WK, et al.: Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA, 2002, 99: 8932-8937. [Medline] [CrossRef]
5. De Coppi P: Regenerative medicine for congenital malformations. J Pediatr Surg, 2013, 48: 273-280. [Medline] [CrossRef]
6. Atala A, Bauer SB, Soker S, et al.: Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet, 2006, 367: 1241-1246. [Medline] [CrossRef]
7. Schächinger V, Erbs S, Elsässer A, et al. REPAIR-AMI Investigators: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med, 2006, 355: 1210-1221. [Medline] [CrossRef]
8. Binder S, Stanzel BV, Krebs I, et al.: Transplantation of the RPE in AMD. Prog Retin Eye Res, 2007, 26: 516-554. [Medline] [CrossRef]
9. Yaniz-Galende E, Chen J, Chemaly E, et al.: Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. Circ Res, 2012, 111: 1434-1445. [Medline] [CrossRef]
10. Christie JD, Edwards LB, Kucheryavaya AY, et al. International Society of Heart and Lung Transplantation: The registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant, 2012, 31: 1073-1086. [Medline] [CrossRef]
11. Bainbridge JW, Smith AJ, Barker SS, et al.: Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med, 2008, 358: 2231-2239. [Medline] [CrossRef]
12. Hatzistergos KE, Quevedo H, Oskouei BN, et al.: Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res, 2010, 107: 913-922. [Medline] [CrossRef]
13. Oberpenning F, Meng J, Yoo JJ, et al.: De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol, 1999, 17: 149-155. [Medline] [CrossRef]
14. Poss KD, Wilson LG, Keating MT: Heart regeneration in zebrafish. Science, 2002, 298: 2188-2190. [Medline] [CrossRef]
15. Porrello ER, Mahmoud AI, Simpson E, et al.: Transient regenerative potential of the neonatal mouse heart. Science, 2011, 331: 1078-1080. [Medline] [CrossRef]
16. Kajstura J, Rota M, Cappetta D, et al.: Cardiomyogenesis in the aging and failing human heart. Circulation, 2012, 126: 1869-1881. [Medline] [CrossRef]
17. Nurkovic J, Dolicanin Z, Tutic I, et al.: Adipose tissue mesenchymal stem cells—isolation, cultivation and induced differentiation. Prax Med, 2013, 42: 45-50.
18. Volarevic V, Bojic S, Nurkovic J, et al.: Stem cells as new agents for the treatment of infertility: current and future perspectives and challenges. Biomed Res Int, 2014, 2014: 507234. [Medline] [CrossRef]
19. Ohlstein B, Kai T, Decotto E, et al.: The stem cell niche: theme and variations. Curr Opin Cell Biol, 2004, 16: 693-699. [Medline] [CrossRef]
20. Schroeder IS: Stem cells: are we ready for therapy? Methods Mol Biol, 2014, 1213: 3-21. [Medline] [CrossRef]
21. Larijani B, Esfahani EN, Amini P, et al.: Stem cell therapy in treatment of different diseases. Acta Med Iran, 2012, 50: 79-96. [Medline]
22. Simovic Markovic B, Nikolic A, Gazdic M, et al.: Pharmacological inhibition of Gal-3 in mesenchymal stem cells enhances their capacity to promote alternative activation of macrophages in dextran sulphate sodium-induced colitis. Stem Cells Int, 2016, 2016: 2640746. [Medline] [CrossRef]
23. Senarath-Yapa K, McArdle A, Renda A, et al.: Adipose-derived stem cells: a review of signaling networks governing cell fate and regenerative potential in the context of craniofacial and long bone skeletal repair. Int J Mol Sci, 2014, 15: 9314-9330. [Medline] [CrossRef]
24. Kim EH, Heo CY: Current applications of adipose-derived stem cells and their future perspectives. World J Stem Cells, 2014, 6: 65-68. [Medline] [CrossRef]
25. Nurkovic J, Volarevic V, Lako M, et al.: Aging of stem and progenitor cells: mechanisms, impact on the therapeutic potential and rejuvenation. Rejuvenation Res, 2016, 19: 3-12 [CrossRef] [Medline]
26. American Physical Therapy Association: Regenerative rehabilitation. http://www.apta.org/ RegenerativeRehab/. (Accessed May 1, 2014)
27. Zheng XX, Sanchez-Fueyo A, Domenig C, et al.: The balance of deletion and regulation in allograft tolerance. Immunol Rev, 2003, 196: 75-84. [Medline] [CrossRef]
28. Scandling JD, Busque S, Dejbakhsh-Jones S, et al.: Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med, 2008, 358: 362-368. [Medline] [CrossRef]
29. Huard J, Li Y, Fu FH: Muscle injuries and repair: current trends in research. J Bone Joint Surg Am, 2002, 84-A: 822-832. [Medline]
30. Prisk V, Huard J: Muscle injuries and repair: the role of prostaglandins and inflammation. Histol Histopathol, 2003, 18: 1243-1256. [Medline]
31. Schmid P, Itin P, Cherry G, et al.: Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol, 1998, 152: 485-493. [Medline]
32. Li Y, Huard J: Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol, 2002, 161: 895-907. [Medline] [CrossRef]
33. Chan YS, Li Y, Foster W, et al.: The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med, 2005, 33: 43-51. [Medline] [CrossRef]
34. Fukushima K, Badlani N, Usas A, et al.: The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med, 2001, 29: 394-402. [Medline]
35. Chan YS, Li Y, Foster W, et al.: Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol 1985, 2003, 95: 771-780. [Medline] [CrossRef]
36. Hawke TJ, Garry DJ: Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 1985, 2001, 91: 534-551. [Medline]
37. Fisher BD, Rathgaber M: An overview of muscle regeneration following acute injury. J Phys Ther Sci, 2006, 18: 57-66. [CrossRef]
38. Sato K, Saida K, Yanagawa T, et al.: Differential responses of myogenic C2C12 cells to hypoxia between growth and muscle-induction phases: growth, differentiation and motility. J Phys Ther Sci, 2011, 23: 161-169. [CrossRef]
39. Brack AS, Conboy MJ, Roy S, et al.: Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science, 2007, 317: 807-810. [Medline] [CrossRef]
40. Carlson ME, Conboy IM: Loss of stem cell regenerative capacity within aged niches. Aging Cell, 2007, 6: 371-382. [Medline] [CrossRef]
41. Ambrosio F, Ferrari RJ, Distefano G, et al.: The synergistic effect of treadmill running on stem-cell transplantation to heal injured skeletal muscle. Tissue Eng Part A, 2010, 16: 839-849. [Medline] [CrossRef]
42. Dreyer HC, Blanco CE, Sattler FR, et al.: Satellite cell numbers in young and older men 24 hours after eccentric exercise. Muscle Nerve, 2006, 33: 242-253. [Medline] [CrossRef]
43. McBride TA, Gorin FA, Carlsen RC: Prolonged recovery and reduced adaptation in aged rat muscle following eccentric exercise. Mech Ageing Dev, 1995, 83: 185-200. [Medline] [CrossRef]
44. Jubrias SA, Esselman PC, Price LB, et al.: Large energetic adaptations of elderly muscle to resistance and endurance training. J Appl Physiol 1985, 2001, 90: 1663-1670. [Medline]
45. Tanaka S, Miyata T, Fujita T, et al.: Differing responses of satellite cell activity to exercise training in rat skeletal muscle. J Phys Ther Sci, 2009, 21: 141-145. [CrossRef]
46. Tanaka S, Kawahara E, Nakagawa T: Myogenic cell response to muscle contraction with short electrical stimulation. J Phys Ther Sci, 2015, 27: 2349-2352. [Medline] [CrossRef]
47. Kondziolka D, Wechsler L, Goldstein S, et al.: Transplantation of cultured human neuronal cells for patients with stroke. Neurology, 2000, 55: 565-569. [Medline] [CrossRef]
48. Kondziolka D, Steinberg GK, Wechsler L, et al.: Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg, 2005, 103: 38-45. [Medline] [CrossRef]
49. Nelson PT, Kondziolka D, Wechsler L, et al.: Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol, 2002, 160: 1201-1206. [Medline] [CrossRef]
50. Lee JS, Hong JM, Moon GJ, et al. STARTING Collaborators: A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells, 2010, 28: 1099-1106. [Medline] [CrossRef]
51. Bhasin A, Srivastava MV, Kumaran SS, et al.: Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra, 2011, 1: 93-104. [Medline] [CrossRef]
52. Honmou O, Houkin K, Matsunaga T, et al.: Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain, 2011, 134: 1790-1807. [Medline] [CrossRef]
53. Park K, Lee S, Hong Y, et al.: Therapeutic physical exercise in neural injury: friend or foe? J Phys Ther Sci, 2015, 27: 3933-3935. [Medline] [CrossRef]
54. Guo ZY, Sun X, Xu XL, et al.: Human umbilical cord mesenchymal stem cells promote peripheral nerve repair via paracrine mechanisms. Neural Regen Res, 2015, 10: 651-658. [Medline] [CrossRef]
55. Wang P, Zhang Y, Zhao J, et al.: Intramuscular injection of bone marrow mesenchymal stem cells with small gap neurorrhaphy for peripheral nerve repair. Neurosci Lett, 2015, 585: 119-125. [Medline] [CrossRef]
56. Seyed Foroutan K, Khodarahmi A, Alavi H, et al.: Bone marrow mesenchymal stem cell and vein conduit on sciatic nerve repair in rats. Trauma Mon, 2015, 20: e23325. [Medline] [CrossRef]
57. Salomone R, Bento RF, Costa HJ, et al.: Bone marrow stem cells in facial nerve regeneration from isolated stumps. Muscle Nerve, 2013, 48: 423-429. [Medline] [CrossRef]
58. Lasso JM, Pérez Cano R, Castro Y, et al.: Xenotransplantation of human adipose-derived stem cells in the regeneration of a rabbit peripheral nerve. J Plast Reconstr Aesthet Surg, 2015, 68: e189-e197. [Medline] [CrossRef]
59. Wei X, Yang X, Han ZP, et al.: Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin, 2013, 34: 747-754. [Medline] [CrossRef]
60. Johnson K, Zhu S, Tremblay MS, et al.: A stem cell-based approach to cartilage repair. Science, 2012, 336: 717-721. [Medline] [CrossRef]
61. Cao L, Yang F, Liu G, et al.: The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials, 2011, 32: 3910-3920. [Medline] [CrossRef]
62. Hwang ES: Senescence suppressors: their practical importance in replicative lifespan extension in stem cells. Cell Mol Life Sci, 2014, 71: 4207-4219. [Medline] [CrossRef]
63. Choudhery MS, Badowski M, Muise A, et al.: Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J Transl Med, 2014, 12: 8. [Medline] [CrossRef]
64. Kim SU, de Vellis J: Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res, 2009, 87: 2183-2200. [Medline] [CrossRef]
65. Reya T, Morrison SJ, Clarke MF, et al.: Stem cells, cancer, and cancer stem cells. Nature, 2001, 414: 105-111. [Medline] [CrossRef]
66. Miura M, Miura Y, Padilla-Nash HM, et al.: Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells, 2006, 24: 1095-1103. [Medline] [CrossRef]
67. Røsland GV, Svendsen A, Torsvik A, et al.: Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res, 2009, 69: 5331-5339. [Medline] [CrossRef]
68. Parsch D, Fellenberg J, Brümmendorf TH, et al.: Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med Berl, 2004, 82: 49-55. [Medline] [CrossRef]
69. Simonsen JL, Rosada C, Serakinci N, et al.: Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol, 2002, 20: 592-596. [Medline] [CrossRef]
70. Zimmermann S, Voss M, Kaiser S, et al.: Lack of telomerase activity in human mesenchymal stem cells. Leukemia, 2003, 17: 1146-1149. [Medline] [CrossRef]
71. Kim WS, Park BS, Sung JH: The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther, 2009, 9: 879-887. [Medline] [CrossRef]
72. Torsvik A, Røsland GV, Svendsen A, et al.: Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track-letter. Cancer Res, 2010, 70: 6393-6396. [Medline] [CrossRef]
73. Ilic D: Industry highlights: stem cell and regenerative medicine. Regen Med, 2011, 6: 55-60. [Medline] [CrossRef]